Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab.
True
David G
DG
Department of Rheumatology, Wilford Hall Medical Center, San Antonio, Texas, USA. dgtrue@yahoo.com
Penmetcha
Mohan
M
Peckham
Steven J
SJ
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D003453:Cryptococcosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D003455:Cryptococcus neoformans / Q000302:isolation & purification*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000008:administration & dosage; D005500:Follow-Up Studies; D016469:Fungemia / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D018570:Risk Assessment; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed
D000911:Antibodies, Monoclonal; D015725:Fluconazole; D000069285:Infliximab; D008727:Methotrexate